Skip to main content
. Author manuscript; available in PMC: 2009 Sep 23.
Published in final edited form as: J Cereb Blood Flow Metab. 2007 Oct 10;28(3):602–611. doi: 10.1038/sj.jcbfm.9600556

Table 1.

Summary of the SVZ growth fraction, cell-cycle phase durations, and experimental interval

Stroke (days) GF (%) Tc-Ts (h) Tc (h) TG1 (h) TG2+M (h) Experimental interval (h)
Nonstroke 20 14.4 19 12.6 1.79 16
2 23.6* 9.2* 11.5* 7.5* 1.79 11
4 30*,# 10.1*,# 12.5*,# 8.3*,# 1.80 11
7 31.*,# 11.4*,# 15.3*,# 9.6*,# 1.78 13
14 24 14.9# 19.7# 13# 1.79 16

IdU, 5-iodo-2′-deoxyuridine; SVZ, subventricular zone.

*

P<0.05 compared with rats without stroke.

#

P<0.05 compared with 2 days after stroke.

Experimental interval indicates a perfuse time after initial IdU injection.